1 In parallel, semaglutide will become generic in some key markets from 2026 onward (e.g., India, China, Brazil), and pressure from compounding pharmacies to meet unmet demand for GLP1 therapies adds another layer of complexity and competition to the evolving treatment landscape
Some patients may experience mild side effects, such as nausea or digestive discomfort, especially when starting a new treatment
Toxicity of vitamin B6 is becoming more common with the symptoms being painful and the cause is typically due to accidentally overdosing via self-prescribing supplements
GLP-1 Lawsuits Targeting Gastrointestinal Injuries Lawsuits alleging gastrointestinal injuries have targeted multiple GLP-1 drugs and their manufacturers
Please consult with your doctor and insurance provider
A licensed healthcare provider must authorize its use